PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 848667

Transverse colon volvulus associated with scleroderma.

D C Budd·E L Nirdlinger·D L Sturtz·W J Fouty
View original source ↗Export metadata ↓

Abstract

An unusual case of volvulus of the transverse colon associated with scleroderma is presented. The morphologic changes in the large bowel due to progressive systemic sclerosis, resulting in pseudo-obstruction, are considered in the etiology and pathogenesis of colonic torsion.

Explore related subjects

Colonic DiseasesFemaleHumansIntestinal ObstructionMiddle AgedRadiographyScleroderma, SystemicCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D C Budd, E L Nirdlinger, D L Sturtz, W J Fouty. 1977. Transverse colon volvulus associated with scleroderma.. https://doi.org/10.1016/0002-9610(77)90547-5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2012

Crohn's disease.

Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the gastrointestinal tract with extraintestinal manifestations and associated immune disorders. Genome wide association studies identified susceptibility loci that--triggered by environmental factors--result in a disturbed innate (ie, disturbed intestinal barrier, Paneth cell dysfunction, endoplasmic reticulum stress, defective unfolded protein response and autophagy, impaired recognition of microbes by pattern recognition receptors, such as nucleotide binding domain and Toll like receptors on dendritic cells and macrophages) and adaptive (ie, imbalance of effector and regulatory T cells and cytokines, migration and retention of leukocytes) immune response towards a diminished diversity of commensal microbiota. We discuss the epidemiology, immunobiology, amd natural history of Crohn's disease; describe new treatment goals and risk stratification of patients; and provide an evidence based rational approach to diagnosis (ie, work-up algorithm, new imaging methods [ie, enhanced endoscopy, ultrasound, MRI and CT] and biomarkers), management, evolving therapeutic targets (ie, integrins, chemokine receptors, cell-based and stem-cell-based therapies), prevention, and surveillance.

Colonic Diseases↗